Drug Trial Radar · NCT03452488
A Double-blind, Placebo-controlled, Randomized INTerventional Clinical Trial (SARA-INT)
Last checked: Nov 19, 2026Latest source record: Oct 1, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
233
Actual
Start
Feb 7, 2017
Primary completion
Apr 26, 2020
Study completion Apr 26, 2020
Sponsor
- Lead sponsor
- BiophytisIndustry
- Sponsor type
- Industry
- First posted
- Mar 2, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main objective of the study is to evaluate the effect of two daily doses of BIO101 versus placebo on mobility function as measured by gait speed using the 400MW test. The absolute change from baseline in meters/second observed in each treatment group at 6 Month was compared to the placebo group. Due to the Covid pandemic \>50% of data at endpoint was missing, which may have affected the ability of the study to deliver the expected results. Additionally, although the planned duration of treatment was 6 months, it was extended up to 9 months for some participants as a result of the pandemic.
Conditions
- Sarcopenia
- Gait Disorders in Old Age
- Muscle Weakness
Interventions
BIO101Drug
Oral capsules
PlaceboDrug
Oral capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline to 6 Months in Gait Speed for 400 Meter Walking (MW) TestTime frame: Baseline and 6 Months
Locations
22 sites in 2 countries. Site status is shown where the registry gives one.
Advanced Clinical Research
Banning, California
SC Clinical Research, Inc
Garden Grove, California
California Research Foundation
San Diego, California
Institut On Aging
Gainesville, Florida
Jax-Ascent University of Florida
Jacksonville, Florida
PANAX Clinical Research
Miami Lakes, Florida
Clinical Research of Central Florida
Plant City, Florida
Pennington Biomedical Research Center
Baton Rouge, Louisiana
Jean Mayer USDA Human Nutrition research Center on Aging Tufts University
Boston, Massachusetts
New Mexico Clinical Research & Osteoporosis Center
Albuquerque, New Mexico
Columbia University
New York, New York
PMJ Research of Wilmington
Wilmington, North Carolina
Bowman Gray Center for Medical Education-of- Wake Forest School of Medicine
Winston-Salem, North Carolina
Tekton Research
Yukon, Oklahoma
Tekton Research
Austin, Texas
Medical Center
Houston, Texas
Science Advancing Medicine Clinical Research Center
San Antonio, Texas
The University of Texas Health Science Center at San Antonio
San Antonio, Texas
Advanced Clinical Research
West Jordan, Utah
Vrije Universiteit Brussel
Brussels, Belgium
Universitaire Ziekenhuizen (UZ) Leuven - Gasthuisberg - Centrum voor metabole botziekten
Leuven, Belgium
Université de Liège
Liège, Belgium
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.